Although previous studies have shown a rescue of several phenotypes in an adult mouse model of Noonan syndrome using PD0325901 at 5 mg/kg bodyweight35, we sought to identify a lower effective dose, since inhibition of the RAS-ERK pathway results in learning deficits36. This evidence concerns the gene MAPK1 and Noonan syndrome.